Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ARRY | Array BioPharma Inc. | -0.24% | 46.26 | 8.1% | $690.49m | |
| AMGN | Amgen Inc. | -0.23% | 177.06 | 1.3% | $495.97m | |
| CELG | Celgene Corporation | -0.72% | 90.87 | 1.3% | $431.27m | |
| GILD | Gilead Sciences, Inc. | -0.03% | 66.92 | 0.9% | $401.89m | |
| BIIB | Biogen Inc. | -0.91% | 229.44 | 1.3% | $372.09m | |
| ILMN | Illumina, Inc. | 0.20% | 302.90 | 3.5% | $354.87m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.35% | 299.42 | 2.6% | $268.31m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.48% | 123.41 | 2.0% | $197.95m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.49% | 154.00 | 14.7% | $197.25m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.56% | 177.14 | 1.9% | $181.72m | |
| A | Agilent Technologies, Inc. | -0.52% | 69.59 | 1.6% | $140.09m | |
| EXAS | Exact Sciences Corporation | 1.21% | 116.34 | 24.1% | $137.96m | |
| INCY | Incyte Corporation | 0.44% | 80.23 | 2.5% | $110.35m | |
| BLUE | Bluebird Bio, Inc. | 4.33% | 139.45 | 14.3% | $97.87m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.12% | 82.47 | 4.3% | $84.42m |
Company Profile
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.